Hunan Fangsheng Pharmaceutical Co Ltd 603998
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥10.93
- Day Range
- ¥11.50–12.02
- 52-Week Range
- ¥7.12–13.09
- Bid/Ask
- ¥12.01 / ¥12.02
- Market Cap
- ¥5.28 Bil
- Volume/Avg
- 17.4 Mil / 5.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.36
- Price/Sales
- 2.89
- Dividend Yield (Trailing)
- 2.65%
- Dividend Yield (Forward)
- 2.65%
- Total Yield
- 2.65%
Company Profile
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,686
- Website
- http://www.fangsheng.com.cn
Comparables
Valuation
|
Metric
|
603998
|
600422
|
002393
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.36 | 28.32 | 26.62 |
Price/Book Value | 3.18 | 2.07 | 0.86 |
Price/Sales | 2.89 | 1.47 | 3.39 |
Price/Cash Flow | 13.92 | 14.27 | 18.01 |
Price/Earnings
603998
600422
002393
Financial Strength
|
Metric
|
603998
|
600422
|
002393
|
|---|---|---|---|
Quick Ratio | 0.39 | 1.38 | 2.89 |
Current Ratio | 0.74 | 1.88 | 3.50 |
Interest Coverage | 10.74 | 33.20 | 169.67 |
Quick Ratio
603998
600422
002393
Profitability
|
Metric
|
603998
|
600422
|
002393
|
|---|---|---|---|
Return on Assets (Normalized) | 5.03% | 3.33% | 2.80% |
Return on Equity (Normalized) | 10.77% | 6.05% | 3.38% |
Return on Invested Capital (Normalized) | 7.30% | 5.18% | 1.92% |
Return on Assets
603998
600422
002393
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Phkfskbrt | Tbqk | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Mmyxblvc | Wpvhdc | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Rcmfwgjt | Ktwz | $48.4 Bil | |||
| Viatris Inc
VTRS
| Cfbwhvp | Bdjn | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Mrfrvjkf | Yphn | $13.5 Bil | |||
| Catalent Inc
CTLT
| Zddwylbqc | Jydvm | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Nshgckft | Jdycxq | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Zstyrhy | Gdm | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Djbtgkjsq | Pjl | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Pppfkcjfh | Lvxg | $2.3 Bil |
United States